Does cardiac development provide heart research with novel therapeutic approaches? [version 1; referees: 2 approved]

• Main Authors: Angeliqua Sayed, Mariana Valente, David Sassoon
• Format: Article
• Language: English
• Published: F1000 Research Ltd 2018-11-01
• Series: F1000Research
• Online Access: https://f1000research.com/articles/7-1756/v1

Embryonic heart progenitors arise at specific spatiotemporal periods that contribute to the formation of distinct cardiac structures. In mammals, the embryonic and fetal heart is hypoxic by comparison to the adult heart. In parallel, the cellular metabolism of the cardiac tissue, including progenitors, undergoes a glycolytic to oxidative switch that contributes to cardiac maturation. While oxidative metabolism is energy efficient, the glycolytic-hypoxic state may serve to maintain cardiac progenitor potential. Consistent with this proposal, the adult epicardium has been shown to contain a reservoir of quiescent cardiac progenitors that are activated in response to heart injury and are hypoxic by comparison to adjacent cardiac tissues. In this review, we discuss the development and potential of the adult epicardium and how this knowledge may provide future therapeutic approaches for cardiac repair.